Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 27 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)				Phase IV				HSC-MS-06-0478 OSP-24412, NCT00581425
	Post-Operative Concurrent Chemo-Radiotherapy Versus Post-Operative Radiotherapy for Cancer of the Head and Neck				Phase III				TROG 05.01 NCT00193895
	Periocular Basal Cell Carcinoma (BCC): Permanent vs. Frozen Section Pathological Control				Phase III				01 NCT00663650
	CERTICOEUR: A Secondary Prevention Study of Skin Cancers in Heart Transplant Patients. Everolimus Versus Calcineurin Inhibitors Multicenter Trial				Phase III				2007.489/32 NCT00799188
	A Phase II Single Arm Open-Label Clinical Trial of Chemotherapy of BCCs With Tazarotene 0.1% in Subjects With Basal Cell Nevus Syndrome				Phase II, Phase I				2007-018 NCT00500643
	An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)				Phase II, Phase I				CTL0408 NCT00652080
	Photodynamic Therapy in Treating Patients With Skin Cancer				Phase II				RPCI-DS-96-55 NCI-G97-1224, NCT00002975
	ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin				Phase II				ID02-282 NCT00054691
	Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFR				Phase II				2005-001098-82 NCT00240682
	A Trial of Erlotinib + Radiotherapy for Cutaneous Squamous Cell Carcinoma				Phase II				F060106002 NCT00369512


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute